Advertisements

Stocking Stuffers

 

Cel-Sci Corporation ($0.001 Par Value) (CVM) Stock Quote

Detailed Quote for Cel-Sci Corporation (CVM)
$ 2.77   0.01 (+0.36%) Volume: 260.03k 8:00 PM EST 20-Feb-2019
Today 5d 1m 3m 1y more
Last Price
2.77
Change $
0.01
Change %
0.36%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
2.76
High
2.90
Low
2.76
Prev Close
2.76
Last Trade
8:00
Volume
260.03k
52 Wk Hi
4.44000005
52 Wk Low
0.816500008
Market Cap
78.64m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
28,388,453
EPS (TTM)
-1.89999997
PE Ratio
N/A
Exchange
NYSE American
News and Media for Cel-Sci Corporation (CVM)
Sector News | Topic News
News for Cel-Sci Corporation (CVM)
Tue, Feb 12, 2019
3:37 PM CEL-SCI (CVM) Presents At BIO CEO & Investor Conference - Slideshow - SeekingAlpha
Thu, Feb 07, 2019
9:00 AM CEL-SCI to Present at 2019 BIO CEO & Investor Conference - Business Wire
Fri, Jan 25, 2019
1:29 PM Cel-Sci And Multikine Immunotherapy In Head And Neck Cancer: High Risk With Great Reward - SeekingAlpha
Wed, Jan 23, 2019
9:20 AM U.S. Patent Office Issues CEL-SCI Two Patents for Its LEAPS Vaccine Platform Technology - Business Wire
Tue, Jan 15, 2019
8:55 AM CEL-SCI regains full listing compliance with NYSE - SeekingAlpha
8:00 AM CEL-SCI Regains Full Listing Compliance with NYSE American - Business Wire
Thu, Dec 20, 2018
11:28 AM Cel-Sci reports FY results - SeekingAlpha
Wed, Dec 19, 2018
7:04 PM CEL-SCI Reports Fiscal 2018 Financial Results and Clinical & Corporate Developments - Business Wire
Fri, Nov 23, 2018
8:55 AM Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group - Discovering Underlying Factors of Influence - GlobeNewswire
More News for CVM >>
Filings for Cel-Sci Corporation (CVM)
Tue, Feb 19, 2019
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Thu, Feb 14, 2019
3:00 AM Quarterly report with a continuing view of a company's financial position - Form 10-Q
Wed, Feb 13, 2019
3:00 AM Amendment to the SC 13G filing - Form SC 13G/A
Mon, Feb 11, 2019
3:00 AM Amendment to general form for registration of securities under the Securities Act of 1933 - Form S-1/A
Fri, Jan 18, 2019
3:00 AM General form for registration of securities under the Securities Act of 1933 - Form S-1
Wed, Jan 02, 2019
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Wed, Dec 19, 2018
3:00 AM Annual report with a comprehensive overview of the company - Form 10-K
Wed, Nov 07, 2018
3:00 AM Securities offered to employees under employee benefit plans - Form S-8
More Filings for CVM >>

Tags for Cel-Sci Corporation ($0.001 Par Value)

Research stocks or mutual funds related to Cel-Sci Corporation ($0.001 Par Value) by keywords or tags. Find companies that have a similar focus to CVM. The keywords below have been associated to CVM by either user submission or electronic means.

biotech research clinical trial enrollment clinical research trial clinical research software laboratory research arthritis causes corporate financial clinical cost disney annual report pharmaceutical study research institutes clinical research consulting Medical Laboratories (8071) annual report asthma clinical trial Biological Products phase iii clinical trials financial report cra clinical research research clinical research technology research phase 3 clinical trials clinical trials manager fda clinical trial medical research immunology reactive arthritis biotechnology research what causes arthritis physician clinical trials Drugs comfort research annual report of company corporate annual report 3m annual report clinical trials recruitment clinical trials conference clinical metabolic research clinical study agreements clinical data Healthcare clinical trial publication clinical research network monitoring clinical research financial statement software clinical research nurse Except Diagnostic Substances (2836) financial statement